Rep. Julie Johnson discloses joint sales of Abbott Laboratories (ABT) and Accenture (ACN) stock, each valued up to $15,000.
- Filer
- Hon. Julie Johnson (TX)
- Transactions
- 2 across 2 companies
- Direction
- 0 bought · 2 sold
- Notification date
- 06/03/2026
All 2 transactions in this filing
Hon. Julie Johnson of Texas's 32nd district filed a Periodic Transaction Report on June 12, 2026, disclosing two stock sales.
Both transactions occurred on May 12, 2026. The first was a sale of Abbott Laboratories Common Stock (ABT) and the second was a sale of Accenture plc Class A Ordinary Shares (ACN). Each sale was valued in the range of $1,001 to $15,000. The total value of the disclosed sales is between $2,002 and $30,000.
Both assets were held jointly. The filing notes that the transactions were associated with a "Merrill Lynch Tax Efficient Core" investment vehicle. The report did not indicate if either sale resulted in capital gains exceeding $200.
Important Disclaimer
Amounts are disclosed by law as broad ranges, not exact figures - this reflects the range as filed, not a precise dollar amount. This content is summarized from a public government disclosure filing and may contain errors.
The Filing Fool is not a registered investment adviser. Nothing here is a recommendation or solicitation to buy, sell, or hold any security, nor any claim about a filer's intent or knowledge.